S100A11 and glioma: It has been reported that expression of S100A11, which correlates with glioma pathological grade, promotes the proliferation and tumorigenic capacity of glioma cells, and knockdown of S100A11 expression using shRNA results in the opposite phenotype (Wang et al. 2021).